Cue Biopharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Cue Biopharma and other ETFs, options, and stocks.About CUE
Cue Biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of a novel and proprietary class of biologic drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its pipeline includes Immuno-oncology, CUE-100 framework, CUE-200 framework, and autoimmune disease.
CEODaniel R. Passeri
CEODaniel R. Passeri
Employees53
Employees53
HeadquartersBoston, Massachusetts
HeadquartersBoston, Massachusetts
Founded2014
Founded2014
Employees53
Employees53
CUE Key Statistics
Market cap69.05M
Market cap69.05M
Price-Earnings ratio-1.37
Price-Earnings ratio-1.37
Dividend yield—
Dividend yield—
Average volume797.83K
Average volume797.83K
High today$1.37
High today$1.37
Low today$1.05
Low today$1.05
Open price$1.25
Open price$1.25
Volume463.96K
Volume463.96K
52 Week high$3.25
52 Week high$3.25
52 Week low$0.45
52 Week low$0.45
CUE News
TipRanks 4d
Cue Biopharma reports Q3 EPS (17c), consensus (19c)Reports Q3 revenue $3.34M, consensus $1.52M. “We are very pleased with the validating updated clinical data from our Phase 1 trials for both CUE-101 and CUE-102...